Nature Nature Park Trading Inc – Trademark Portfolio
Entity Type: 03
Nature Nature Park Trading Inc holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include GLOFEST, MEDIXIA, SNAZIFY, VITAIFIX, and VITAVERVE. The owner is based in Longmont, CO.
1935 Main St
Longmont, CO 80501
Showing of trademarks Trademarks
Trademark Classifications
Nature Nature Park Trading Inc's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Nature Nature Park Trading Inc have?
Nature Nature Park Trading Inc has 6 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 abandoned.
What trademark classes does Nature Nature Park Trading Inc file in?
Nature Nature Park Trading Inc files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Nature Nature Park Trading Inc's most well-known trademarks?
Nature Nature Park Trading Inc's registered trademark portfolio includes well-known marks such as GLOFEST, MEDIXIA, SNAZIFY, VITAIFIX, and VITAVERVE. These are among 5 currently registered trademarks in the portfolio.
What is Nature Nature Park Trading Inc's trademark registration success rate?
Nature Nature Park Trading Inc has a 83% trademark registration rate, with 5 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.